Effects of age and sex on ketamine-induced hyperactivity in rats

Physiology and Behavior

Volumn 91, Issue 2-3, 2007, Pages 202-207

  Wilson, Christopher ^a   Kercher, Melanie ^a   Quinn, Belsida ^a   Murphy, Alexandra ^a   Fiegel, Carey ^a   McLaurin, Angel ^a  

^a SAM HOUSTON STATE UNIVERSITY   (United States)

Author keywords

Hyperactivity; Ketamine; Rats

Indexed keywords

KETAMINE;

AGE DISTRIBUTION; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG DOSE INCREASE; DRUG EFFECT; FEMALE; HEAD MOVEMENT; HYPERACTIVITY; LOCOMOTION; MALE; NONHUMAN; OPEN FIELD BEHAVIOR; PRIORITY JOURNAL; RAT; REARING; SEX DIFFERENCE; TORQUE;

EID: 34248633365     PISSN: 00319384     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.physbeh.2007.02.010     Document Type: Article

References (36)

1. Jentsch J.D., and Roth R.H. The neuropsychopharmacology of phencyclidine: from NMDA receptor hypofunction to the dopamine hypothesis of schizophrenia. Neuropsychopharmacology 20 (1999) 201-225
2. Vollenweider F.X., Vontobel P., Oye I., Hell D., and Leenders K.L. Effects of (S)ketamine on striatal dopamine: a [-sup-1-sup-1C] raclopride PET study of a model psychosis in humans. J Psychiat Res 34 (2000) 35-43
3. White J.M., and Ryan C.F. Pharmacological properties of ketamine. Drug Alcohol Rev 15 (1996) 145-155
4. Giuliani D., and Ferrari F. Involvement of dopamine receptors in the antipsychotic profile of (-)eticlopride. Physiol Behav 61 (1997) 563-567
5. Tricklebank M.D., Singh L., Oles R.J., Preston C., and Iversen S.D. The behavioural effects of MK-801: a comparison with antagonists acting non-competitively and competitively at the NMDA receptor. Eur J Pharmacol 167 (1989) 127-135
6. McCullough L.D., and Salamone J.D. Increases in extracellular dopamine levels and locomotor activity after direct infusion of phencyclidine into the nucleus accumbens. Brain Res 577 (1992) 1-9
7. Feldman R.S., Meyer J.S., and Quenzer L.F. Principles of neuropsychopharmacology (1997), Sinauer, Sunderland, MA
8. Johnson K.M. Phencyclidine: behavioral and biochemical evidence supporting a role for dopamine. Fed Proc 42 (1983) 2579-2583
9. French E.D., and Ceci A. Non-competitive N-methyl-d-aspartate antagonists are potent activators of ventral tegmental A10 dopamine neurons. Neurosci Lett 119 (1990) 159-162
10. Bowyer J.F., Spuhler K.P., and Weiner N. Effects of phencyclidine, amphetamine and related compounds on dopamine release from and uptake into striatal synaptosomes. J Pharmacol Exp Ther 229 (1984) 671-680
11. Murray T.F., and Horita A. Phencyclidine-induced stereotyped behavior in rats: dose-response effects and antagonism by neuroleptics. Life Sci 24 (1979) 2217-2226
12. Schlemmer R.J., Jackson J.A., Preston K.L., and Davis J.M. Phencyclidine-induced stereotyped behavior in monkeys: antagonism by pimozide. Eur J Pharmacol 52 (1978) 379-384
13. Yamamoto M., Mizuki Y., Suetsugi M., Ozawa Y., Ooyama M., and Suzuki M. Effects of dopamine antagonists on changes in spontaneous EEG and locomotor activity in ketamine-treated rats. Pharmacol Biochem Behav 57 (1997) 361-365
14. Spear L.P., and Brake S.C. Periadolescence: age-dependent behavior and psychopharmacological responsivity in rats. Dev Psychobiol 16 (1983) 83-109
15. Laviola G., Wood R.D., Kuhn C., Francis R., and Spear L.P. Cocaine sensitization in periadolescent and adult rats. J Pharmacol Exp Ther 275 (1995) 345-357
16. Bolanos C.A., Glatt S.J., and Jackson D. Subsensitivity to dopaminergic drugs in periadolescent rats: a behavioral and neurochemical analysis. Dev Brain Res 111 (1998) 25-33
17. Frantz K.J., and Van Hartesveldt C. The locomotor effects of quinpirole in rats depend on age and gender. Pharmacol Biochem Behav 64 (1999) 821-826
18. Honack D., and Loscher W. Sex differences in NMDA receptor mediated responses in rats. Brain Res 620 (1993) 167-170
19. Scalzo F.M., and Burge L.J. The ontogeny of phencyclidine-induced wall climbing and locomotor activity. Dev Psychobiol 25 (1992) 597-612
20. Jacobs P.S., Taylor B.M., and Bardgett M.E. Maturation of locomotor and Fos responses to the NMDA antagonists, PCP and MK801. Dev Brain Res 122 (2000) 91-95
21. Wilson C., Cone K., Kercher M., Hibbitts J., Fischer J., Van Lake A., et al. Naloxone increases ketamine-induced hyperactivity in the open field in female rats. Pharmacol Biochem Behav 81 (2005) 530-534
22. National Academy of Sciences Guide for the Care and Use of Laboratory Animals. Natl. Acad, Sci. (1996). http://www.nap.edu/readingroom/books/labrats/ www.nap.edu/readingroom/books/labrats/
23. Compton R.P., Contreras P.C., O'Donohue T.L., and Monahan J.B. The N-methyl-d-aspartate antagonist, 2-amino-7-phosphonoheptanoate, produces phencyclidine-like behavioral effects in rats. Eur J Pharmacol 136 (1987) 133-134
24. A pharmacological manipulations on ethanol sensitivity in immature and mature animals. Alcohol Clin Exp Res 26 (2002) 449-456
25. Frantz K.J., and Van Hartesveldt C. Locomotion elicited by MK801 in developing and adult rats: temporal, environmental, and gender effects. Eur J Pharmacol 369 (1999) 145-157
26. Koek W., Woods J.H., and Ornstein P. A simple and rapid method for assessing similarities among directly observable behavioral effects of drugs: PCP-like effects of 2-amino-5-phosphonovalerate in rats. Psychopharmacology 91 (1987) 297-304
27. Moghaddam B., and Adams B.W. Reversal of phencyclidine effects by a group II metabotropic glutamate receptor agonist in rats. Science 281 (1998) 1349-1352
28. McDonald J.W., and Johnston M.V. Physiological and pathophysiological roles of excitatory amino acids during central nervous system development. Brain Res Revs 15 (1990) 41-70
29. Nabeshima T., Yamaguchi K., Yamada K., Hiramatsu M., Kuwabara Y., Furukawa H., et al. Sex-dependent differences in the pharmacological actions and pharmacokinetics of phencyclidine in rats. Eur J Pharmacol 97 (1984) 217-227
30. Chaturvedi A.K. Effects of mecamylamine, nicotine, atropine and physostigmine on the phencyclidine-induced behavioral toxicity. Pharmacol Biochem Beh 20 (1984) 559-566
31. Snell L.D., and Johnson K.M. Antagonism of N-methyl-d-aspartate-induced transmitter release in the rat striatum by phencyclidine-like drugs and its relationship to turning behavior. J Pharmacol Exp Ther 235 (1985) 50-57
32. Wedzony K., and Czyrak A. The role of corticosteroids in the acquisition of sensitization to locomotor stimulant effect of MK-801. Brain Res 657 (1994) 351-356
33. Pechnick R.N., George R., and Poland R.E. Characterization of the effects of the acute and repeated administration of MK-801 on the release of adrenocorticotropin, corticosterone and prolactin in the rat. Eur J Pharmacol 164 (1989) 257-263
34. Dotson J.W., Ackerman D.L., and West L.J. Ketamine abuse. J Drug Iss 25 (1995) 751-757
35. Smith G.S., Schloesser R., Brodie J.D., Dewey S.L., Logan J., Vitkun S.A., et al. Glutamate modulation of dopamine measured in vivo with positron emission tomography (PET) and -sup-1-1C-raclopride in normal human subjects. Neuropsychopharmacology 18 (1998) 18-25
36. Awounda M. Swedes alarmed at ketamine misuse. Lancet 348 (1996) 122